相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Broadening the phenotypic spectrum of the presumably epilepsy-related SV2A gene variants
Magdalena Badura-Stronka et al.
EPILEPSY RESEARCH (2023)
Synaptic Vesicle Glycoprotein 2A: Features and Functions
Rachele Rossi et al.
FRONTIERS IN NEUROSCIENCE (2022)
A de novo heterozygous rare variant in SV2A causes epilepsy and levetiracetam-induced drug-resistant status epilepticus
Daniel G. Calame et al.
EPILEPSY & BEHAVIOR REPORTS (2021)
An Epilepsy-Associated SV2A Mutation Disrupts Synaptotagmin-1 Expression and Activity-Dependent Trafficking
Callista B. Harper et al.
JOURNAL OF NEUROSCIENCE (2020)
Levetiracetam-induced a new seizure type in a girl with a novel SV2A gene mutation
Di Wang et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2019)
Homozygous Mutation in Synaptic Vesicle Glycoprotein 2A Gene Results in Intractable Epilepsy, Involuntary Movements, Microcephaly, and Developmental and Growth Retardation
Fatema J. Serajee et al.
PEDIATRIC NEUROLOGY (2015)
SV2 regulates neurotransmitter release via multiple mechanisms
Amy Nowack et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
BA Lynch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)